Análisis geoestadístico desde el laboratorio clínico en prevención cardiovascular para atención primaria

Martín Pérez, Salomón; Arrobas Velilla, Teresa; Iglesia, Juan Fabiani de la; Vázquez Rico, Ignacio; Varo Sánchez, Gema; León-Justel, Antonio.
Clín. investig. arterioscler. (Ed. impr.) ; 35(2): 75-84, Mar-Abr. 2023. map, tab, graf
Artículo en Español | IBECS (España) | ID: ibc-219213

Documentos relacionados

  1. Geostatistical analysis from the clinical laboratory in cardiovascular prevention for primary care.
  2. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles
  3. The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study.
  4. Significance of lipids, lipoproteins, and apolipoproteins during the first 14-16 months of life.
  5. Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolism.
  6. Influencia de la concentración de triglicéridos en la lipoproteína(a) en función de la dislipidemia
  7. Lipid Profile and Lipoprotein(a) Testing.
  8. Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers.
  9. Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study.
  10. Quantifying the contribution of lipoprotein(a) to all apoB containing particles.